Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders

Overview of attention for article published in Frontiers in Medicine, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
twitter: 7 X users

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 64 Dimensions

Readers on

mendeley: 131 Mendeley

Summary News X Wikipedia Dimensions citations

So far, Altmetric has seen 1 news story.

Akero Therapeutics: What Is Making The Stock Tick

Seeking Alpha, 23 Nov 2022

Follow Summary In September, AKRO went up on solid phase 2b data. MDGL, which also has strong phase 2 data, is toplining phase…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.